Treat-and-repair Strategy for Atrial Septal Defect with Eisenmenger Syndrome due to Pulmonary Arterial Hypertension.

Intern MedJan 15, 2026 (epub)

Muneyuki Kadota, Shusuke Yagi, Satoshi Akagi et al.

✦ AI-curated · Sources linked

Case in brief

A 53-year-old man with Eisenmenger syndrome from a large secundum atrial septal defect had severe pulmonary arterial hypertension. After escalation of PAH-specific therapy, his hemodynamics improved markedly, with substantial reductions in pulmonary pressure and vascular resistance. He then underwent successful surgical ASD closure with a fenestrated patch. The report describes symptomatic and hemodynamic improvement with this treat-and-repair approach in a patient who responded favorably to medical therapy.

What made this case unusual

Despite Eisenmenger syndrome and severe PAH, the patient’s favorable response to intensified medical therapy allowed fenestrated surgical closure of the ASD.

Diagnostic / clinical pearl

In this case, marked hemodynamic improvement on PAH-specific therapy preceded fenestrated ASD closure; the treat-and-repair approach was used in a patient with Eisenmenger syndrome and severe PAH.

Source

Published in Intern Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.